Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: PDL who wrote (1755)	2/18/1999 4:35:00 PM
From: billy d	Read Replies (2) \| Respond to of 10280

Tremendous day but I must admit its a bit scary to here projections of analyst estimates being conservative coming from the CFO when SEPR doesn't even have an approved product selling yet. (excluding Allegra) What do you guys say to this? Do you think it possible that all of the ongoing trials look so good that SEPR already knows that approval is virtually a lock on all of them. I can't see how they can make that statement without some serious confidence of what is going on in the lab right now. Simply amazing.